Jean Paul Viard

Tritherapy for Human Immunodeficiency Virus Infection Does Not Modify Replication of Hepatitis C Virus in Coinfected Subjects

Hervé Zylberberg, Marie‐Laure Chaix, Cécile Rabian et al. · Clinical Infectious Diseases · 1998 · 93 citations

Life Sciences, Immunology, Infectious Diseases +17

Time to Virological Failure of 3 Classes of Antiretrovirals after Initiation of Highly Active Antiretroviral Therapy: Results from the EuroSIDA Study Group

Amanda Mocroft, Bruno Ledergerber, Jean Paul Viard et al. · The Journal of Infectious Diseases · 2004 · 87 citations · Full text

Life Sciences, Infectious Diseases, Pharmacology +17

Dolutegravir and lamivudine maintenance therapy in HIV-1 virologically suppressed patients: results of the ANRS 167 trial (LAMIDOL)

Véronique Joly, Charles Burdet, Roland Landman et al. · Journal of Antimicrobial Chemotherapy · 2018 · 80 citations

Pharmacy, Infectious Diseases, Pharmacotherapy +17

Passive Immunotherapy in AIDS: A Randomized Trial of Serial Human Immunodeficiency Virus-Positive Transfusions of Plasma Rich in p24 Antibodies versus Transfusions of Seronegative Plasma

Daniel Vittecoq, B. Mattlinger, Françoise Barré‐Sinoussi et al. · The Journal of Infectious Diseases · 1992 · 72 citations

Veterinary Medicine, Immunology, Infectious Diseases +11

Human Herpesvirus 8–Positive Castleman Disease in Human Immunodeficiency Virus–Infected Patients: The Impact of Highly Active Antiretroviral Therapy

Laurent Aaron, Olivier Lidove, Chérine Yousry et al. · Clinical Infectious Diseases · 2002 · 66 citations · Full text

Life Sciences, Immunology, Infectious Diseases +17